Chin Augmentation Market Size, Share & Trends Analysis Report By Procedure (Surgical, Non-Surgical), By Gender (Female, Male), By End-use (Cosmetic Surgery Centers, Hospitals, MedSpas), By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global chin augmentation market size was valued at USD 1.20 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.8% from 2023 to 2030. Chin augmentation is the cosmetic procedure to enhance the chin size via alloplastic implants, bone advancements, or dermal fillers. The market is expected to grow due to several factors, such as changing beauty standards in developing countries, growing financial accessibility to aesthetic procedures, increasing regulatory approval for dermal fillers, and growing cosmetic demand from the aging population. According to the American Society of Plastic Surgeons, 25% of chin augmentation procedures were recorded in those aged between 55 and 69.

The pandemic had a negative impact on the market. Cosmetic voluntary procedures were halted due to COVID-19, and the beds were allocated to the patients afflicted by the Sars-Cov-2. According to the International Society of Aesthetic Plastic Surgery (ISAPS), cosmetic surgical procedures declined by 10.9% in 2020 from 2019. In addition, a similar source stated that the usage of hyaluronic acid in non-surgical cosmetic procedures declined by 6.1% in 2020. However, the market recovered from the pandemic losses due to the changing customer perception levels. As per the survey conducted by ISAPS in 2021, 61.6% of worldwide cosmetic surgeons reported having attained the pre-pandemic level of patient volumes.

The growing financing options to undergo aesthetic surgeries aid the market. Financing options make chin augmentation and other cosmetic procedures more accessible to a broader range of potential patients, which positively aids the market growth. For example, companies such as Prosper Healthcare Lending provide financing options for aesthetic procedures. In addition, the company has funded over USD 5 billion for cosmetic procedures. Furthermore, in April 2022, AbbVie & PatientFi expanded their partnership, as the latter company introduced financing options for AbbVie’s aesthetic products, such as Juvederm, BOTOX, and others. Such marketing agreements are expected to boost market during the forecast period.

The increasing demand for cosmetic procedures from the aging population is expected to drive market growth during the forecast period. According to an article on NCBI, the aging patient group is the fastest-growing population undergoing cosmetic procedures. According to different studies, chin augmentation procedures are commonly performed in patients undergoing facelifts, and facelifts are more commonly performed in older patients. Hence, the market is expected to be positively aided by this trend.

In addition, the growing number of cosmetic procedures performed on men is expected to drive the market for chin augmentation, as this aesthetic procedure strengthens the chin projection, making the facial appearance highly masculine. Moreover, various literature studies have concluded a strong correlation between rhinoplasty (nose jobs) and chin augmentation procedures to be performed together. According to ISAPS, 25.8% of rhinoplasty procedures were performed on men in 2021.

Procedure Insights

Based on procedure, market is segmented into surgical and non-surgical. The surgical segment dominated the market with a revenue share of 69.62% in 2022. Chin implants are considered the “gold” standard chin augmentation procedure owing to advantages such as long-lasting surgical results, ease of performing the procedure, and comparative cost advantage over bone advancement procedures. Moreover, chin implant materials such as MedPor and Gore-Tex are gaining immense market traction owing to improved tissue ingrowth and fibrovascularization.

The non-surgical segment is estimated to be the fastest-growing, with a CAGR of 7.5% during the forecast period. Dermal filler products based on hyaluronic acid, calcium hydroxylapatite, and Polymethyl-methacrylate microspheres are commonly used for chin augmentation procedures. Moreover, growing product approvals are expected to boost market growth. For instance, in February 2021, Galderma received FDA approval for its hyaluronic acid (HA) product, Restylane Defyne, for chin augmentation.

Gender Insights

Based on gender, the market is segmented into females and males. The female segment dominated the market with a revenue share of 79.19% in 2022. According to ISAPS 2021 Report, it was estimated that 86.1% of all cosmetic surgical & 86.5% of all non-surgical cosmetic procedures were performed on women. Moreover, according to a survey published by RealSelf in 2019, more than one in four women in the U.S. considered undergoing a cosmetic procedure in the upcoming periods.

However, the male segment is estimated to be the fastest growing, with a CAGR of 7.5% during the forecast period. According to the British Association of Aesthetic Plastic Surgeons (BAAPS), cosmetic surgical procedures in men increased by 121% in 2022 from the previous year. Similarly, the Association of German Aesthetic Plastic Surgeons stated an increase of 15.6% in 2022 for men undergoing minimally invasive aesthetic surgeries. Such trends are expected to drive the growth of the segment over the forecast period.

End-use Insights

Based on end-use, the market is segmented into cosmetic surgery centers, hospitals, and medspas. Cosmetic surgery centers dominated the market with a revenue share of 54.92% in 2022. The dominant share is attributed as chin augmentation procedures are primarily performed on an outpatient basis. Moreover, cosmetic surgery centers have experienced and board-certified plastic surgeons who specialize in facial procedures, and have access to a range of anesthesia options, including local anesthesia, twilight sedation, or general anesthesia.

However, the medspas segment is estimated to be the fastest-growing, with a CAGR of 8.0% during the forecast period. Chin filler procedures or non-surgical chin augmentation procedures are primarily performed by medspas owing to the low patient downtime and non-invasive nature of cosmetic surgery. According to the American Med Spa Association, 8,841 medspas were operational in 2022. Moreover, medspas offers customer-friendly services such as subscription discounts, loyalty programs, and others which augments their demand for chin augmentation procedures.

Regional Insights

North America dominated the global chin augmentation market and accounted for 34.95% of the total market share in 2022. The growth can be attributed to the high acceptance rate for cosmetic surgeries amongst the population, technological advancements in both surgical and non-surgical techniques, and accessibility and availability of skilled professionals. Moreover, the ISAPS audit states that 85.7% of the cosmetic practices in the U.S. returned to pre-pandemic patient levels in 2021.

Asia-Pacific is expected to witness the fastest CAGR of 8.3% over the forecast period. The growth can be attributed to the growing number of patients from developed nations considering countries such as India, China, and Thailand for aesthetic procedures. Moreover, dominant aesthetic companies are recording an increased revenue flow from developing Asian countries which is expected to have a positive impact on the region’s growth. For instance, in 2022, Merz Aesthetics' revenue from Thailand was recorded at USD 30 million, which was 111% more than the company’s target. Such trends are expected to boost the market during the forecast period.

Key Companies & Market Share Insights

The market is highly competitive, with a large number of manufacturers, The market players are focusing on various strategic initiatives such as new product launches, geographical expansion, mergers and acquisitions, collaboration, product upgradation, and partnerships. For instance, in January 2023, Juvederm VOLUX XC received FDA approval to treat adults aged 21 years and above to treat moderate to severe loss of jawline volume. Some of the prominent key service providers in the global chin augmentation market include:

• New York Plastic Surgical Group

• Westlake Dermatology & Cosmetic Surgery

• Nazarian Plastic Surgery

• Ruby Surgery & Aesthetics

• Cadogan Clinics

• UK Aesthetic

• UK Healthcare Aesthetics Center

• Marroquin & Sandoval Plastic Surgery

• Advanced Cosmetic Surgery.

• Orange County Facial Plastic Surgery.

Chin Augmentation Market Report Scope

Global Chin Augmentation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global chin augmentation market report based on procedure, gender, end-use, and region:

• Procedure Outlook (Revenue, USD Billion, 2018 - 2030)

  • Surgical

    • Chin Implant

    • Bone Advancement

  • Non-Surgical

• Gender Outlook (Revenue, USD Billion, 2018 - 2030)

  • Female

  • Male

• End-use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Cosmetic Surgery Centers

  • Hospitals

  • MedSpas

• Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE

    • Kuwait